Chronic Granulomatous Disease: a Comprehensive Review
The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.
Abstract
Chronic granulomatous disease (CGD) is a primary immunodeficiency of phagocyte function due to defective NADPH oxidase (phox). Compared with the common types of CYBB/gp91 phox, NCF1/p47 phox, and CYBA/p22 phox deficiency, NCF4/p40 phox deficiency is a mild and atypical form of CGD without invasive bacterial or fungal infections. It can be diagnosed using serum-opsonized E.coli as a stimulus in dihydrorhodamine (DHR) assay. Patients with CYBC1/Eros deficiency, a new and rare form of CGD, present as loss of respiratory burst and gp91 phox expression in phagocytes. Neutrophils from patients with CGD are deficient in neutrophil extracellular traps (NETosis), autophagy, and apoptosis. The hyper-activation of NF-ĸB and inflammasome in CGD phagocytes also lead to long-lasting production of pro-inflammatory cytokines and inflammatory manifestations, such as granuloma formation and inflammatory bowel disease-like colitis. Patients with CGD and X-linked female carriers also have a higher incidence of autoimmune diseases. The implementation of antimicrobial, anti-fungal, and interferon-γ prophylaxis has greatly improved overall survival. Residual NADPH oxidase activity is significantly associated with disease severity and the chance of survival of the patient. New therapeutic approaches using immunomodulators for CGD-related inflammatory manifestations are under investigation, including pioglitazone, tamoxifen, and rapamycin. Hematopoietic stem cell transplantation (HSCT) is the curative treatment. Outcomes of HSCT have improved substantially over the last decade with overall survival more than 84-90%, but there are debates about designing optimal conditioning protocols using myeloablative or reduced-intensity regimens. The gene therapy for X-linked CGD using hematopoietic stem and progenitor cells transduced ex vivo by lentiviral vector encoding the human gp91phox gene demonstrated persistence of adequate oxidase-positive neutrophils in a small number of patients. Gene therapy using genome-editing technology such as CRISPR/Cas9 nucleases is a promising approach for patients with CGD in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Individuals with chronic granulomatous disease (CGD), a genetic disorder caused by hypo- or amorphic mutations in genes encoding for Nox2 or its subunits, fail to produce sufficient amounts of ROS by Nox2 and in consequence suffer from increased susceptibility to infections [236]”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [236]
Citations
Cites
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062 · cited 1×
“CRISPR/Cas9 nucleases, guided by a designed single-guide RNA complementary to the target site of interest, can achieve efficient DSB, which undergo repair by non-homologous end joining (NHEJ) causing insertions or deletions or by homology-directed repair (HDR) allowing donor DNA incorporation [87].”
BackgroundProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
TALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650
Tangye, S. G., Al-Herz, W., Bousfiha, A., Chatila, T., Cunningham-Rundles, C., Etzioni, A., Franco, J. L., Holland, S. M., Klein, C., Morio, T., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-019-00737-x · Cited by 1,210 · cited 1×
“It is a rare primary immunodeficiency disease characterized by recurrent life-threatening bacterial, fungal infections, and tissue granuloma formation, which is caused by defects in genes encoding the subunits of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex [2].”
BackgroundHLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
Gragert, L., Eapen, M., Williams, E., Freeman, J., Spellman, S., Baitty, R., Hartzman, R., Rizzo, J. D., Horowitz, M., Confer, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmsa1311707 · Cited by 1,103 · cited 2×
“However, advances in HLA typing technology, GVHD prophylaxis, and management of complications have substantially reduced the risk of mortality, and HSCT from an alternative donor has been increasingly safe and feasible [69, 72].”
BackgroundOtt, M. G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kühlcke, K., Schilz, A., Kunkel, H., et al. (2006) · Nature Medicine · doi:10.1038/nm1393 · Cited by 1,051
Genetic, Biochemical, and Clinical Features of Chronic Granulomatous Disease
Segal, B. H., Leto, T. L., Gallin, J. I., Malech, H. L., & Holland, S. M. (2000) · Medicine · doi:10.1097/00005792-200005000-00004 · Cited by 883
A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease
The International Chronic Granulomatous Disease Cooperative Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240801 · Cited by 830
Cited by
Functions of ROS in Macrophages and Antimicrobial Immunity
Herb, M., & Schramm, M. (2021) · Antioxidants · doi:10.3390/antiox10020313 · Cited by 633
“chronic granulomatous disease (CGD), a genetic disorder caused by hypo- or amorphic mutations in genes encoding for Nox2 or its subunits, fail to produce sufficient amounts of ROS by Nox2 and in consequence suffer from increased susceptibility to infections [236] underscoring the importance of Nox2-derived ROS for ant…”
BackgroundNeutrophils: from IBD to the gut microbiota
Danne, C., Skerniskyte, J., Marteyn, B., & Sokol, H. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00871-3 · Cited by 222
“In CGD, neutrophils can phagocytose microorganisms but are unable to kill them owing to a defect in NADPH oxidase-dependent ROS production 76 .”
Teixeira-Santos, L., Albino‐Teixeira, A., & Pinho, D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105280 · Cited by 114
Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst
Tomlinson, K. L., Riquelme, S. A., Baskota, S. U., Drikic, M., Monk, I. R., Stinear, T. P., Lewis, I. A., & Prince, A. S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112064 · Cited by 111
Cellular and molecular mechanisms breaking immune tolerance in inborn errors of immunity
Sogkas, G., Atschekzei, F., Adriawan, I. R., Dubrowinskaja, N., Witte, T., & Schmidt, R. E. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00626-z · Cited by 100
Metadata
- Authors
- Yu, H.-H., Yang, Y.-H., & Chiang, B.-L.
- Affiliations
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
- Corresponding author
- Chiang, Bor-Luen
- Venue
- Clinical Reviews in Allergy & Immunology
- Published
- 2020-06-10
- Volume
- 61
- Issue
- 2
- Pages
- 101-113
- ISSN
- 1080-0549 (ISSN-L)
- 1559-0267
- OpenAlex
- W3033126525
- Cited by
- 197
- References
- 102
- Citations by year
- 2026: 29 · 2025: 45 · 2024: 22 · 2023: 47 · 2022: 26 · 2021: 25 · 2020: 3
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Clinical Reviews in Allergy & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Taiwan University Hospital (109-A152)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Keywords
- chronic granulomatous disease, NADPH oxidase deficiency, neutrophil extracellular traps, autophagy, apoptosis, NF-κB activation, inflammasome, granuloma formation, autoimmune disease, hematopoietic stem cell transplantation, gene therapy, lentiviral vectors, CRISPR/Cas9 genome editing, immunomodulators
- MeSH terms
- Animals, Granulomatous Disease, Chronic, Humans, Neutrophils, Genetic Therapy, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Granulomatous Disease: a Comprehensive Review. https://app.cochat.ai/papers/10.1007/s12016-020-08800-x
- The paper
- Yu, H.-H., Yang, Y.-H., & Chiang, B.-L. (2021). Chronic Granulomatous Disease: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-020-08800-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.